NEWARK, Del., Aug. 25, 2026 — The global Bioinformatics in IVD Testing Market is expanding as diagnostic laboratories increasingly incorporate software-driven analysis, variant interpretation, knowledge management, and controlled reporting into molecular and genomic testing workflows. According to Future Market Insights (FMI), the market is projected to grow from USD 6.8 billion in 2026 to USD 19.6 billion by 2036, registering a 11.1% CAGR during the forecast period. Growth is being...

The non-sterile probe cover market is growing as hospitals, diagnostic centers, clinics, and ambulatory surgical centers focus on hygiene, patient safety, equipment protection, and infection-prevention practices. The market was valued at USD 700 million in 2024 and is expected to grow from USD 800 million in 2025 to USD 1.2 billion by 2035, registering a CAGR of 4.4%.wiseguyreports Non-sterile probe covers are protective barriers used with medical probes and related diagnostic equipment....

The micro surgery instruments market is growing as hospitals and surgical centers adopt precision tools for complex procedures in neurosurgery, ophthalmology, cardiac surgery, orthopedic surgery, and plastic surgery. The market was valued at USD 3.5 billion in 2024 and is projected to reach USD 5.6 billion by 2035, growing at a CAGR of 4.4%.wiseguyreports Microsurgery involves procedures performed on very small and delicate structures, including nerves, blood vessels, tissues, and anatomical...

The research antibodies and reagents market is expanding as pharmaceutical companies, biotechnology firms, academic institutions, and contract research organizations increase investment in genomics, proteomics, diagnostics, and drug discovery. The market was valued at USD 8.02 billion in 2024 and is projected to reach USD 12.1 billion by 2032, growing at a CAGR of 5.28%.wiseguyreports Research antibodies and reagents are essential tools in modern life-sciences research. They help scientists...

The natural health supplement market is expanding as consumers increasingly prioritize preventive healthcare, nutrition, immune support, fitness, and healthy ageing. The market was valued at USD 197.77 billion in 2024 and is projected to reach USD 300 billion by 2032, growing at a CAGR of 5.35%.wiseguyreports Rising health consciousness is the market’s central growth driver. Consumers are looking for products that can complement healthier diets and lifestyles, particularly as concerns...

The gastrointestinal stent market is growing as healthcare providers increasingly use minimally invasive technologies to manage obstructions in the digestive tract. The market was valued at USD 1.96 billion in 2024 and is projected to reach USD 3.0 billion by 2032, expanding at a CAGR of 5.48%.wiseguyreports Gastrointestinal stents are medical devices used to help maintain or restore passage through narrowed or blocked areas of the digestive tract. They are used across applications involving...

The newborn screening for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) market is growing as healthcare systems prioritize early detection of rare but serious genetic disorders. The market was valued at USD 2.09 billion in 2024 and is projected to reach USD 3.2 billion by 2032, growing at a CAGR of 5.48%.wiseguyreports SMA affects motor neurons and can lead to progressive muscle weakness, while SCID severely affects immune-system function and can leave infants...

The single use consumables market is expanding as hospitals, diagnostic laboratories, clinics, and research organizations prioritize hygiene, infection control, convenience, and operational efficiency. The market was valued at USD 3.38 billion in 2024 and is projected to grow from USD 3.87 billion in 2025 to USD 14.82 billion by 2035, registering a CAGR of 14.38%.marketresearchfuture Single use consumables include consumable instruments and accessories, procedure kits, laboratory products,...

Homecare is becoming one of the fastest-growing end-use settings in the soft mist inhalers market. As chronic respiratory conditions require ongoing management, patients increasingly prefer devices that can be used safely and effectively outside hospitals and clinics.marketresearchfuture The report identifies hospitals and clinics as the largest end-use segment because they provide specialist assessment, diagnosis, treatment planning, and care for severe respiratory disease. However,...

The biosimilar bevacizumab market is growing as healthcare systems seek more affordable oncology treatments without compromising established treatment standards. The market was valued at USD 1.81 billion in 2024, is estimated at USD 1.98 billion in 2025, and is projected to reach USD 4.69 billion by 2035, registering a CAGR of 9.02%.marketresearchfuture Bevacizumab is used across several oncology indications, including colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell...

Regulation is central to the Software as a Medical Device market because clinical software must demonstrate safety, effectiveness, cybersecurity, and appropriate performance. The report identifies regulatory streamlining for adaptive algorithms as a significant market driver.marketresearchfuture AI models can change over time as they are retrained or updated. This creates a challenge for regulators and developers because changes must be managed carefully to ensure that updated software...

The C-reactive protein test market is growing as healthcare systems place greater emphasis on preventive care, chronic disease management, and early assessment of inflammatory conditions. The market was valued at USD 3.55 billion in 2024 and is projected to reach USD 5.5 billion by 2032, at a CAGR of 5.63%.wiseguyreports C-reactive protein, or CRP, is an inflammatory marker used within broader clinical evaluation. Testing demand is supported by the prevalence of cardiovascular disease,...